Cancer Drugs: A Long Road to Blockbuster Sales
Amid high hopes, investors shouldn’t forget how tricky cancer-drug development is
Novel cancer treatments are the next big hope for the drug sector. But investors shouldn’t forget that reward goes hand in hand with risk.
While enthusiasm for the sector gas cooled from the euphoria of the past few years, potential treatments such as immunotherapy, which tries to leverage the body’s immune system to fight disease, remain a bright spot.
Home / Cancer Right / Cancer Drugs: A Long Road to Blockbuster Sales